AMPA Receptor Potentiators: Application for Depression and Parkinson's Disease

E-ISSN： 1873-5592|8|5|603-620

ISSN： 1389-4501

Source： Current Drug Targets, Vol.8, Iss.5, 2007-05, pp. : 603-620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AMPA Receptor Potentiators as Novel Antidepressants

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1511-1527

Bentham Science Publishers

Access to resources Recommend Favorite

AMPA Receptor Potentiators for the Treatment of CNS Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 3, 2004-06 ,pp. : 181-194

Bentham Science Publishers

Access to resources Recommend Favorite

Ring-Fused Thiadiazines as Core Structures for the Development of Potent AMPA Receptor Potentiators

Current Medicinal Chemistry, Vol. 17, Iss. 30, 2010-10 ,pp. : 3575-3582

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Eugenol on the Central Nervous System: Its Possible Application to Treatment of Alzheimer's Disease, Depression, and Parkinson's Disease

Current Bioactive Compounds, Vol. 2, Iss. 1, 2006-03 ,pp. : 57-66

Bentham Science Publishers

Access to resources Recommend Favorite

ECT in Parkinson's disease, with and without depression

By Trimble M.R.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 245-245

Elsevier

Access to resources Recommend Favorite